Abiopharma

Clinical trial NCT07610278 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-05-29

Clinical trial NCT07464314 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 225 → 1475 participants

Clinical trial NCT07518459 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-26 3. primary completion date: 2026-05-28 → 2026-05-26 4. enrollment: 8 → 16 participants

Clinical trial NCT07042945 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-17 → 2026-06-05 3. primary completion date: 2026-07-08 → 2026-06-05 4. enrollment: 28 → 15 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03651128 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-04-08 → 2026-04-13 3. primary completion date: 2027-04-08 → 2026-04-13 4. enrollment: 381 → 386 participants

Clinical trial NCT05059522 updates: 1. completion date: 2026-09-30 → 2026-12-31 2. primary completion date: 2026-09-30 → 2026-12-31 3. enrollment: 68 → 77 participants

Clinical trial NCT05172960: primary completion date: 2025-07-22 → 2027-07-01.

Clinical trial NCT07570992: enrollment: 80 → 58 participants.

Clinical trial NCT06052631: start date: 2026-06-23 → 2026-06-24.

Clinical trial NCT05196035 updates: 1. completion date: 2027-08-31 → 2027-06-30 2. primary completion date: 2027-07-31 → 2027-05-31